Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Rgene

Rgene
2014 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$491K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of enabling enzyme reagents for molecular biotechnology. The company develops enabling enzyme reagents using protein engineering and data mining methods for molecular biotechnology.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Rgene’s full profile, request a free trial.

Rgene Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 27-Mar-2015 $491K Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Rgene Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Institute of General Medical Sciences Government 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0

Rgene Executive Team (1)

Name Title Board
Seat
Contact
Info
Yu Zheng Ph.D Founder & President